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Introduction:
Alzheimer disease (AD), a commonly occurring progressive neurodegenerative disorder in aged people results in severe cognitive deficits [1, 2] with typical pathological changes such as amyloid beta (Aβ) deposition in brain parenchyma and vessels [3] [4] [5] [6] , neurofibrillary tangles formation [7] [8] [9] [10] , and neuronal loss. Even though a small percentage of the patients carry AD associated genetic mutants, approximately 98% of AD onset occurs in a sporadic manner and the mechanism of AD pathogenesis remains largely unknown. Among the reported possible pathogenic factors for AD, extracellular as well as intracellular Aβ [11, 12] is considered to play a central role. It remains unclear however, which type of Aβ species plays a major role and whether Aβ is the initiating factor in AD. Aβ is reported to impact a diverse array of cellular properties, including disruption of cell membrane integrity, and disturbance of organelle function and intracellular homeostasis. Despite its various impact on neurons, increasing evidence is focused on Aβ-mediated mitochondrial dysfunction in AD. Known Aβ related mitochondrial dysfunctions including mitochondrial DNA mutation [13] [14] [15] , decreased glucose metabolism [16, 17] , decreased mitochondrial respiratory chain activity [18, 19] , deactivation of certain key enzymes [16, [18] [19] [20] [21] [22] , increased reactive oxygen species (ROS) generation [18, 19, [23] [24] [25] [26] [27] [28] [29] [30] and perturbed calcium homeostasis [18, 22, [31] [32] [33] have been widely observed in AD patients, AD animal models and in Aβ-treated cell cultures. Recent studies have demonstrated that Aβ induced mitochondrial dynamic changes, including decrease in mitochondrial movement and mitochondrial fission/fusion perturbations
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ACCEPTED MANUSCRIPT [34, 35] . These observations significantly increase our understanding of mitochondrial perturbation relevant to the pathogenesis of AD. Furthermore, progressive accumulation of mitochondrial Aβ in the AD brain and in the AD mouse model implicates the role of mitochondrial Aβ in mitochondrial malfunction [16, 18, 27, 36] . Although the precise role of Aβ in mitochondria is not yet defined, reports clearly show that interaction of mitochondrial Aβ with mitochondrial proteins, amyloid-beta (Aβ) binding alcohol dehydrogenase (ABAD), and cyclophilin D exacerbates mitochondrial and neuronal stress in transgenic AD mouse models [16, 18, 22, 27] .
Notably, the involvement of mitochondrial permeability transition pore (mPTP)
is implicated in Aβ-induced mitochondrial dysfunction, such as perturbation of intracellular calcium regulation, ROS generation, release of pro-apoptotic factors and changes in mitochondrial morphology. This assumption is deduced from the facts that calcium and ROS are strong inducers of the mPTP formation and that the consequence of mPTP formation are increased ROS generation, decreased ATP production and apoptogenic substance release accompanied by mitochondrial swelling [37] [38] [39] [40] . For instance, the absence of cyclophilin D, a key component of mPTP, protects against Aβ-mediated mitochondrial, neuronal and synaptic dysfunction [18, 22] . These studies added significant dimension to our knowledge about the mechanism of Aβ toxicity as well as AD pathogenesis. This review contains a discussion of the role of Aβ-induced mPTP formation in the induction of mitochondrial dysfunction and its relevance to the pathogenesis of AD .
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nonselective pathway, named mitochondrial permeability transition pore (mPTP) [45] [46] [47] [48] .
The molecular basis of mPTP
Although the presence of mPTP formation has long been proposed and widely proven, until recent years the molecular basis of mPTP was not clearly delineated. The structure of the pore is believed to composed of three compartments: ANT are necessary, it is generally accepted that CypD is a necessary compartment for mPTP formation, especially in the most commonly occurring scenarios when calcium levels are not high enough to trigger the CypD independent mPTP formation.
Consequences of mPTP formation
Once formed, mPTP constitutes a non-selective, high conductance pore Based on the findings in the preceding paragraphs, one may conclude that
CypD is the most important initiating molecule for mPTP, and that mPTP formation results in severe mitochondrial dysfunction, irreversible cell damage and finally cell death.
Amyloid beta (Aβ) and mPTP
Aβ is the product of amyloid precursor protein with cultured neurons from nontransgenic littermate controls [18, 22] . Taken together, these studies offer strong evidence that ROS and calcium dysregulation induced by
Aβ is involved in mPTP formation.
Cyclophilin D involves in Aβ-mediated mPTP perturbation
Expression of CypD in AD brain and from mAPP mice
In view of the known key role of CypD in mPTP function, investigation was undertaken to assess whether alternations in CypD expression are associated with AD
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pathology. Findings revealed that expression of CypD was significantly elevated in Aβ-containing cortical mitochondria from AD-affected regions (temporal pole and hippocampus) as compared to non-AD cortical mitochondria of age-matched non-AD patients. There was not a significant difference in CypD expression in cerebellum between human AD and non-AD brains (Fig. 1A) . Further, increased level of CypD in AD correlate to the presence of mitochondrial Aβ in AD brains [18] . Consistent with the observations of human AD brain, transgenic (Tg) mice expressing a mutant form of human amyloid precursor protein (mAPP mice) displayed age-dependent elevated level of CypD in the cerebral cortex (including the hippocampus) as compared with non transgenic (nonTg) littermate controls (Fig. 1B) [18, 22] . These results suggest that alternations in CypD expression may impact the pathogenesis of AD in addition to its known role in age-related cellular perturbation.
Given the fact that Cyp D is the critical molecule in mPTP formation and CypD ablation prevents mPTP formation, it has been proposed that increased CypD favors the opening of mPTP [18, 22, 71, 72] . Recent studies indicate that high level of CypD in neuronal mitochondria increase vulnerability to mPTP and require higher level of CSA to inhibit mPTP opening [73] . In contrast, neuronal cells with decreasing level of CypD become less sensitive to mPTP induction. Previous studies from our laboratory demonstrate that mAPP cortical mitochondria have a higher level of CypD as well as increased CypD translocation to the IMM, calcium-induced mitochondrial swelling, and decreased calcium buffering capacity. These deleterious effects on mitochondrial properties are largely blocked by CypD deletion and the addition of
CSA [18, 22] . This indicates that increased CypD in mAPP mice leads to decreased mPTP formation threshold, although these data should be interpreted with reservation since existing mitochondrial dysfunction in mAPP mice may be a factor in mitochondrial response to calcium. 
Blockade of CypD protects against Aβ-induced mitochondrial and neuronal toxicity
CypD plays a key role in stabilizing mitochondrial permeability transition pulses revealed that changes in calcium uptake capacity occurred in an age-dependent manner in both nonTg and mAPP mice. When compared to mice aged 3 to 6 months, nonTg mice showed a trend towards reduction of calcium uptake capacity by up to 13 A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT
22-24 months old; of note, however, mAPP mice showed a decreased brain mitochondrial calcium uptake capacity as compared to nonTg mice ( Fig. 2A) . At 3 months of age, both nonTg and mAPP mice possess adequate calcium buffering capacity. In contrast, impaired capacity for Ca 2+ uptake begins at 6 months of age and progressively decreased in 12 and 22-24 months old mAPP mice with reductions of ~18%, ~50%, and ~58% respectively, as compared to the 3 months old mAPP mice ( Fig. 2A) uptake capacity (Fig. 2B) .
To determine the effect of mPTP on calcium handling ability of Aβ-rich mitochondria from mAPP mice, the next logical step includes measurement of mitochondrial swelling in response to Ca
2+
. Cortical mitochondria from transgenic and nonTg mice showed swelling in response to Ca 2+ , whereas mAPP mitochondria displayed increased swelling compared to nonTg mitochondria at the mice ages of 12 and 22-24 months although both cortical mitochondria of nonTg and mAPP mice exhibited an age-dependent increased swelling in response to Ca 2+ ( Fig. 3) [18, 22] .
Importantly, CypD-deficient mAPP mitochondria (mAPP/Ppif -/-) were more resistant to swelling and permeability transition induced by Ca 2+ than mAPP mitochondria (Fig. 3) [18, 22] . The addition of CSA to the mAPP mitochondria also attenuated swelling in response to Ca 2+ (Fig 3) [18, 22] . The inhibitory effect of CSA on Ca To fully evaluate mitochondrial function, we measured the inner mitochondrial membrane potential (∆Ψm) in brain slices in situ. Brain slices from Tg mice were loaded with tetramethylrhodamine methyl ester (TMRM) to assess inner mitochondrial ΔΨm. The intensity of TMRM staining was significantly decreased in the cerebral cortices and hippocampi from 12 months old mAPP mice compared to nonTg mice. In contrast, mitochondria from CypD-deficient mAPP mice were largely resistant to the loss of ∆Ψm demonstrating a higher TMRM staining intensity compared to mitochondria from single mAPP mice [18] . Thus, the ∆Ψm of mitochondria lacking CypD is protected from Aβ-mediated swelling and opening of the membrane permeability transition pore.
As mitochondria are the principal sites of generation of ROS, and Aβ is known to trigger oxidative stress, we tested whether CypD-Aβ interaction correlates with ROS generation in mitochondria. To evaluate mitochondrial ROS generation, mice were injected intravenously with MitoSox Red, a novel fluorogenic dye for highly selective detection of superoxide production in the mitochondria of live cells. The enhancing Aβ clearance [76, 77] and stabilizing calcium homeostasis [78, 79] .
Blockade of CypD improves synaptic function and learning memory in an AD mouse
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Compared to those strategies that mainly focus on keeping mitochondria from insults by eliminating damage causative factors, studies about blocking massive mPTP formation are at an advantage as they focus on increasing mitochondrial resistance to existing harmful insults. New insights into mitochondrial permeability transition pore and Aβ enables us delving into AD pathogenesis to find an efficient ways to protect
mitochondria. CypD inhibition is a feasible and possibly significant therapeutic approach. Cyclosporine A, an inhibitor of CypD broadly used in a clinical application, might be a potential therapeutic option for the treatment of AD. However, in terms of the potential toxic effects of CSA, such as the immunosuppressive effect [80] , the usage of CSA in the treatment of AD would be likely limited. Searching for a novel agent that selectively targets CypD, mPTP, or a mimetic of CSA without toxic effects is still a rational approach to AD therapy.
Conclusions
Aβ mitochondrial toxicity has been intensively studied, whereas the precise mechanism(s) is largely unknown. The development of research on the involvement of Aβ in mPTP formation enhances our knowledge regarding Aβ These severe mitochondrial perturbations lead to multiple cellular stresses, neuron death and finally deficits in learning/memory ability.
